Sangui BioTech International, Inc. ("SGBI") is a holding company the shares of which are being traded on the pink market. Its purpose is to provide financing and access to the capital markets for the enterprises of the Sangui group. SGBI has been a reporting company since 2000 and is current in its filings with the SEC.

Mölnlycke releases Granulox® in the Middle East & Africa

Acquistion of SastoMed by Mölnlycke - future relation with Sangui

"Motivations and goals following the acquisition of SastoMed GmbH by the Mölnlycke Group"